Jeanne M. Clark
Rutgers, The State University of New Jersey · 395 works · 33,606 citations · h-index 82
Top works
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- The Prevalence and Etiology of Elevated Aminotransferase Levels in The United States
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- Nonalcoholic fatty liver disease
- Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis
- The epidemiology of nonalcoholic fatty liver disease in adults.
- Comparative Effectiveness of Weight-Loss Interventions in Clinical Practice
- The Epidemiology of Nonalcoholic Fatty Liver Disease: A Global Perspective
- Association of an Intensive Lifestyle Intervention With Remission of Type 2 Diabetes
- Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits
- Prevalence of Nonalcoholic Fatty Liver Disease in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994
- Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
- Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial
- Clinical, Laboratory and Histological Associations in Adults with Nonalcoholic Fatty Liver Disease†
- Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus
- Nonalcoholic Fatty Liver Disease
- Four‐Year Weight Losses in the Look AHEAD Study: Factors Associated With Long‐Term Success
- Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study
- Teaching the teachers
- Serum Ferritin and Risk of the Metabolic Syndrome in U.S. Adults